/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Genzyme Corp. Genzyme Corp. (GENZ) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 54.87\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n 0.38\n\n (+0.70%)\n\n \n\n \n\n \n\n \n\n Volume: 0\n\n \n\n \n\n\n\n 4:00 PM EST Feb 9, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
February 13,2009
\n \n
Close: \n 73.75\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
August 10,2009
\n \n
Close: \n 47.09\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
54.87
\n 		\n\n \n \n \n
Change $
\n \n 0.38\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 0.70%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
54.80
\n 		\n \n \n \n\n
Bid Size
100
\n 		\n \n \n \n
Ask
58.00
\n\n 		\n \n \n \n
Ask Size
100
\n
\n \n \n \n
Open
55.02
\n 		\n \n \n \n
High
55.47
\n 		\n\n \n \n \n
Low
54.27
\n 		\n \n\n \n \n
Prev Close
54.49
\n
\n \n\n \n \n
Last Trade
2/9/10
\n 		\n \n \n \n
Volume
0
\n 		\n \n \n \n
\n
52 Wk Hi
73.75
\n 		\n\n \n \n \n
52 Wk Low
47.09
\n
\n \n\n \n \n
Market Cap
14.56 b
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
265,382,892
\n 		\n \n \n \n
EPS (TTM)
1.75
\n 		\n \n \n \n\n
PE Ratio
31.40
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
Nasdaq Global Select (NGS)
\n
\n
\n
\n
\n
\n \n
Exchange
NGS
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Genzyme Corp.\n\n \n\n  (GENZ) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for GENZ\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Feb 10, 2010
\n\n \n\n\n\n
7:30 AM\n\n\n\n Mipomersen Phase 3 Study in Patients with Heterozygous Familial Hypercholesterolemia Meets Primary Endpoint - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Feb 03, 2010
\n\n \n\n\n\n
9:12 AM\n\n\n\n Scott Canute Joins Genzyme to Head Manufacturing and Corporate Operations - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 29, 2010
\n\n \n\n\n\n
9:20 AM\n\n\n\n Genzyme Strengthens Role of Board's Lead Independent Director - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 28, 2010
\n\n \n\n\n\n
8:30 AM\n\n\n\n Genzyme Adopts New Incentive Compensation Plans for Senior Executives - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 21, 2010
\n\n \n\n\n\n
10:27 AM\n\n\n\n Genzyme's Lumizyme BLA Receives Six-Month FDA Review - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jan 12, 2010
\n\n \n\n\n\n
12:03 PM\n\n\n\n Genzyme Reports Fourth-Quarter Revenue - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jan 08, 2010
\n\n \n\n\n\n
8:54 AM\n\n\n\n Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 07, 2010
\n\n \n\n\n\n
8:44 AM\n\n\n\n Genzyme and Relational Investors Enter Into Mutual Cooperation Agreement - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 17, 2009
\n\n \n\n\n\n
7:08 AM\n\n\n\n Benchmark Journal Analytical Research on Companies Within Financial, Healthcare and Technology Sectors - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Dec 09, 2009
\n\n \n\n\n\n
8:30 AM\n\n\n\n Genzyme Laboratory Recognized for Quality - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 08, 2009
\n\n \n\n\n\n
5:18 PM\n\n\n\n Robert J. Bertolini Elected to Genzyme's Board of Directors - Business Wire
8:30 AM\n\n\n\n Genzyme's Mozobil Shows Promise in Chemosensitization - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Dec 07, 2009
\n\n \n\n\n\n
3:35 PM\n\n\n\n Genzyme Phase 3 Trial of Campath/Fludara Combination Shows Potential Benefit in Second-Line CLL - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Dec 04, 2009
\n\n \n\n\n\n
10:02 AM\n\n\n\n PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 03, 2009
\n\n \n\n\n\n
8:42 AM\n\n\n\n Genzyme to Reopen Enrollment in Alglucosidase Alfa Temporary Access Program - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Dec 02, 2009
\n\n \n\n\n\n
9:01 AM\n\n\n\n Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 01, 2009
\n\n \n\n\n\n
9:02 AM\n\n\n\n Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant - Business Wire
6:51 AM\n\n\n\n Wall St Sense Reviews Key Players in the Basic Materials, Healthcare, Technology and Utilities Sectors - Marketwire
6:50 AM\n\n\n\n StockPreacher.com Issues Analyst Blog Review for Clarient Inc. - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Nov 26, 2009
\n\n \n\n\n\n
8:10 AM\n\n\n\n Health Canada/Information Update: Foreign Particles Found in Certain Products From Genzyme - Marketwire Canada
\n\n More News for GENZ >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");